Total synthesis of (-)-salinosporamide A

Chemistry - An Asian Journal

Volumn 6, Issue 1, 2011, Pages 209-219

  Kaiya, Yuji ^a   Hasegawa, Jun Ichi ^a   Momose, Takayuki ^a   Sato, Takaaki ^a   Chida, Noritaka ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

carbohydrates; inhibitors; natural products; rearrangement; total synthesis

Indexed keywords

BENZYL ESTERS; D-ARABINOSE; DEPROTECTION; FUNCTIONALIZATIONS; FUNCTIONALIZED; INHIBITORS; LACTAM STRUCTURE; LEWIS ACID; NATURAL PRODUCTS; ONE POT; OVERMAN REARRANGEMENT; PROTECTIVE GROUP; PYRANOSE; REARRANGEMENT; SALINOSPORAMIDE A; STEREO-SELECTIVE; STEREOCENTERS; TOTAL SYNTHESIS;

CARBOHYDRATES; CARBOXYLIC ACIDS; DRUG PRODUCTS; ESTERS; SCAFFOLDS; STEREOSELECTIVITY;

SYNTHESIS (CHEMICAL);

LACTONE; PYRROLE DERIVATIVE; SALINOSPORAMIDE A;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

LACTONES; MOLECULAR STRUCTURE; PYRROLES;

EID: 78650773335     PISSN: 18614728     EISSN: 1861471X     Source Type: Journal    
DOI: 10.1002/asia.201000602     Document Type: Article

References (133)

1. For selected recent reviews on proteasomes and their inhibitors, see J. Adams, Curr. Opin. Oncol. 2002, 14, 628-634
2. J. Adams, Drug Discovery Today 2003, 8, 307-315
3. P. M. Voorhees, E. C. Dees, B. O'Neil, R. Z. Orlowski, Clin. Cancer Res. 2003, 9, 6316-6325
4. S. V. Rajkumar, P. G. Richardson, T. Hideshima, K. C. Anderson, J. Clin. Oncol. 2005, 23, 630-639
5. I. Zavrski, C. Jakob, P. Schmid, H. Krebbel, M. Kaiser, C. Fleissner, M. Rosche, K. Possinger, O. Sezer, Anti-Cancer Drugs 2005, 16, 475-481
6. A. Ciechanover, Angew. Chem. 2005, 117, 6095-6119
7. Angew. Chem. Int. Ed. 2005, 44, 5944-5967
8. L. Borissenko, M. Groll, Chem. Rev. 2007, 107, 687-717
9. E. Genin, M. Reboud-Ravaux, J. Vidal, Curr. Top. Med. Chem. 2010, 10, 232-256.
10. For selected reviews on natural products with γ-lactam-β- lactone structures, see E. J. Corey, W.-D. Z. Li, Chem. Pharm. Bull. 1999, 47, 1-10
11. C. E. Masse, A. J. Morgan, J. Adams, J. S. Panek, Eur. J. Org. Chem. 2000, 2513-2528
12. M. Shibasaki, M. Kanai, N. Fukuda, Chem. Asian J. 2007, 2, 20-38
13. B. C. Potts, K. S. Lam, Mar. Drugs 2010, 8, 835-880.
14. S. Omura, T. Fujimoto, K. Otoguro, K, Matsuzaki, R. Moriguchi, H. Tanaka, Y. Sasaki, J. Antibiot. 1991, 44, 113-116
15. S. Omura, K. Matsuzaki, T. Fujimoto, K. Kosuge, T. Furuya, S. Fujita, A. Nakagawa, J. Antibiot. 1991, 44, 117-118.
16. G. Fenteany, R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, S. L. Schreiber, Science 1995, 268, 726-731.
17. L. R. Dick, A. A. Cruikshank, L. Grenier, F. D. Melandri, S. L. Nunes, R. L. Stein, J. Biol. Chem. 1996, 271, 7273-7276
18. L. R. Dick, A. A. Cruikshank, A. T. Destree, L. Grenier, T. A. McCormack, F. D. Melandri S. L. Nunes, V. J. Palombella, L. A. Parent, L. Plamondon, R. L. Stein, J. Biol. Chem. 1997, 272, 182-188.
19. For total syntheses of lactacystin (2), see E. J. Corey, G. A. Reichard, J. Am. Chem. Soc. 1992, 114, 10677-10678
20. T. Sunazuka, T. Nagamitsu, K. Matsuzaki, H. Tanaka, S. Omura, A. B. Smith III, J. Am. Chem. Soc. 1993, 115, 5302
21. H. Uno, J. E. Baldwin, A. T. Russell, J. Am. Chem. Soc. 1994, 116, 2139-2140
22. N. Chida, J. Takeoka, N. Tsutsumi, S. Ogawa, J. Chem. Soc. Chem. Commun. 1995, 793-794
23. T. Nagamitsu, T. Sunazuka, H. Tanaka, S. Omura, P. A. Sprengeler, A. B. Smith III, J. Am. Chem. Soc. 1996, 118, 3584-3590
24. E. J. Corey, W. Li, T. Nagamitsu, Angew. Chem. 1998, 110, 1784-1787
25. Angew. Chem. Int. Ed. 1998, 37, 1676-1679
26. N. Chida, J. Takeoka, K. Ando, N. Tsutsumi, S. Ogawa, Tetrahedron 1997, 53, 16287-16298
27. E. J. Corey, W. Li, G. A. Reichard, J. Am. Chem. Soc. 1998, 120, 2330-2336
28. J. S. Panek, C. E. Masse, Angew. Chem. 1999, 111, 1161-1163
29. Angew. Chem. Int. Ed. 1999, 38, 1093-1095
30. H. Ooi, N. Ishibashi, Y. Iwabuchi, J. Ishihara, S. Hatakeyama, J. Org. Chem. 2004, 69, 7765-7768
31. E. P. Balskus, E. N. Jacobsen, J. Am. Chem. Soc. 2006, 128, 6810-6812
32. N. Fukuda, K. Sasaki, T. V. R. S. Sastry, M. Kanai, M. Shibasaki, J. Org. Chem. 2006, 71, 1220-1225
33. C. J. Hayes, A. E. Sherlock, M. P. Green, C. Wilson, A. J. Blake, M. D. Selby, J. C. Prodger, J. Org. Chem. 2008, 73, 2041-2051. For formal syntheses of 2, see
34. S. H. Kang, H.-S. Jun, Chem. Commun. 1998, 1929-1930
35. S. Iwama, W.-G. Gao, T. Shinada, Y. Ohfune, Synlett 2000, 1631-1633
36. M. P. Green, J. C. Prodger, C. J. Hayes, Tetrahedron Lett. 2002, 43, 6609-6611
37. C. J. Brennan, G. Pattenden, G. Rescourio, Tetrahedron Lett. 2003, 44, 8757-8760
38. D. J. Wardrop, E. G. Bowen, Chem. Commun. 2005, 5106-5108
39. C. J. Hayes, A. E. Sherlock, M. D. Selby, Org. Biomol. Chem. 2006, 4, 193-195
40. G. Pattenden, G. Rescourio, Org. Biomol. Chem. 2008, 6, 3428-3438
41. A. Hameed, A. J. Blake, C. J. Hayes, Synlett 2010, 535-538.
42. For total syntheses of omuralide (3), see ref.[6m]
43. F. Soucy, L. Grenier, M. L. Behnke, A. T. Destree, T. A. McCormack, J. Adams, L. Plamondon, J. Am. Chem. Soc. 1999, 121, 9967-9976
44. T. J. Donohoe, H. O. Sintim, L. Sisangia, J. D. Harling, Angew. Chem. 2004, 116, 2343-2346
45. Angew. Chem. Int. Ed. 2004, 43, 2293-2296
46. T. J. Donohoe, H. O. Sintim, L. Sisangia, K. W. Ace, P. M. Guyo, A. Cowley, J. D. Harling, Chem. Eur. J. 2005, 11, 4227-4238
47. C. H. Yoon, D. L. Flanigan, K. S. Yoo, K. W. Jung, Eur. J. Org. Chem. 2007, 37-39; for formal syntheses of 3, see
48. C. B. Gilley, M. J. Buller, Y. Kobayashi, Org. Lett. 2007, 9, 3631-3634
49. J.-C. Legeay, N. Langlois, J. Org. Chem. 2007, 72, 10108-10113.
50. For selected analogue syntheses, see G. Fenteany, R. F. Standaert, G. A. Reichard, E. J. Corey, S. L. Schreiber, Proc. Natl. Acad. Sci. USA 1994, 91, 3358-3362
51. E. J. Corey, W.-D. Z. Li, Tetrahedron Lett. 1998, 39, 7475-7478
52. L. R. Reddy, J.-F. Fournier, B. V. S. Reddy, E. J. Corey, J. Am. Chem. Soc. 2005, 127, 8974-8976
53. P. C. Hogan, E. J. Corey, J. Am. Chem. Soc. 2005, 127, 15386-15387
54. R. A. Shenvi, E. J. Corey, J. Am. Chem. Soc. 2009, 131, 5746-5747.
55. For TMC-95A-D as another type of proteasome inhibitors, see
56. Y. Koguchi, J. Kohno, M. Nishio, K. Takahashi, T. Okuda, T. Ohnuki, S. Komatsubara, J. Antibiot. 2000, 53, 105-109; for total syntheses of TMC-95A, see
57. S. Lin, S. J. Danishefsky, Angew. Chem. 2002, 114, 530-533
58. Angew. Chem. Int. Ed. 2002, 41, 512-515
59. M. Inoue, H. Sakazaki, H. Furuyama, M. Hirama, Angew. Chem. 2003, 115, 2758-2761
60. Angew. Chem. Int. Ed. 2003, 42, 2654-2657
61. B. K. Albrecht, R. M. Williams, Proc. Natl. Acad. Sci. USA 2004, 101, 11949-11954.
62. For epoxomicin as another type of proteasome inhibitor, see M. Hanada, K. Sugawara, K. Kaneta, S. Toda, Y. Nishiyama, K. Tomita, H. Yamamoto, M. Konishi, T. Oki, J. Antibiot. 1992, 45, 1746-1752
63. L. Meng, R. Mohan, B. H. B. Kwok, M. Elofsson, N. Sin, C. M. Crews, Proc. Natl. Acad. Sci. USA 1999, 96, 10403-10408; for total synthesis of 5, see
64. S. Katukojvala, K. N. Barlett, S. D. Lotesta, L. J. Williams, J. Am. Chem. Soc. 2004, 126, 15348-15349.
65. For the isolation and biology of salinosporamide A (1), see R. H. Feling, G. O. Buchanan, T. J. Mincer, C. A. Kauffman, P. R. Jensen, W. Fenical, Angew. Chem. 2003, 115, 369-371
66. Angew. Chem. Int. Ed. 2003, 42, 355-357
67. D. Chauhan, L. Catley, G. Li, K. Podar, T. Hideshima, M. Velankar, C. Mitsiades, N. Mitsiades, H. Yasui, A. Letai, H. Ovaa, C. Berkers, B. Nicholson, T.-H. Chao, S. T. C. Neuteboom, P. Richardson, M. A. Palladino, K. C. Anderson, Cancer Cell 2005, 8, 407-419
68. M. Groll, R. Huber, B. C. M. Potts, J. Am. Chem. Soc. 2006, 128, 5136-5141
69. W. Fenical, P. R. Jensen, M. A. Palladino, K. S. Lam, G. K. Lloyd, B. C. Potts, Bioorg. Med. Chem. 2009, 17, 2175-2180.
70. L. R. Reddy, P. Saravanan, E. J. Corey, J. Am. Chem. Soc. 2004, 126, 6230-6231
71. A. Endo, S. J. Danishefsky, J. Am. Chem. Soc. 2005, 127, 8298-8299
72. L. R. Reddy, J.-F. Fournier, B. V. S. Reddy, E. J. Corey, Org. Lett. 2005, 7, 2699-2701
73. N. P. Mulholland, G. Pattenden, I. A. S. Walters, Org. Biomol. Chem. 2006, 4, 2845-2846
74. G. Ma, H. Nguyen, D. Romo, Org. Lett. 2007, 9, 2143-2146
75. T. Ling, V. R. Macherla, R. R. Manam, K. A. McArthur, B. C. M. Potts, Org. Lett. 2007, 9, 2289-2292
76. K. Takahashi, M. Midori, K. Kawano, J. Ishihara, S. Hatakeyama, Angew. Chem. 2008, 120, 6340-6342
77. Angew. Chem. Int. Ed. 2008, 47, 6244-6246
78. T. Fukuda, K. Sugiyama, S. Arima, Y. Harigaya, T. Nagamitsu, S. Omura, Org. Lett. 2008, 10, 4239-4242
79. H. Nguyen, G. Ma, D. Romo, Chem. Commun. 2010, 10, 4803-4805
80. Y. Sato, H. Fukada, M. Tomizawa, T. Masaki, M. Shibuya, N. Kanoh, Y. Iwabuchi, Heterocyles 2010, 81, 2239-2246.
81. V. Caubert, N. Langlois, Tetrahedron Lett. 2006, 47, 4473-4475
82. V. Caubert, J. Massé, P. Retailleau, N. Langlois, Tetrahedron Lett. 2007, 48, 381-384
83. I. Villanueva Margalef, L. Rupnicki, H. W. Lam, Tetrahedron 2008, 64, 7896-7901
84. R. A. Mosey, J. J. Tepe, Tetrahedron Lett. 2009, 50, 295-297
85. J. R. Struble, J. W. Bode, Tetrahedron 2009, 65, 4957-4967
86. T. Momose, Y. Kaiya, J. Hasegawa, T. Sato, N. Chida, Synthesis 2009, 2983-2991
87. T. Ling, B. C. Potts, V. R. Macherla, J. Org. Chem. 2010, 75, 3882-3885; for structure-activity relationship studies of 1, see
88. V. R. Macherla, S. S. Mitchell, R. R. Manam, K. A. Reed, T.-H. Chao, B. Nicholson, G. Deyanat-Yazdi, B. Mai, P. R. Jensen, W. F. Fenical, S. T. C. Neuteboom, K. S. Lam, M. A. Palladino, B. C. M. Potts, J. Med. Chem. 2005, 48, 3684-3687.
89. L. E. Overman, J. Am. Chem. Soc. 1974, 96, 597-599
90. L. E. Overman, J. Am. Chem. Soc. 1976, 98, 2901-2910; for reviews on Overman rearrangements, see
91. L. E. Overman, Acc. Chem. Res. 1980, 13, 218-224
92. L. E. Overman, N. E. Carpenter, in Organic Reactions, Vol.66 (Ed.:, L.E. Overman,), Wiley, New York, NY, 2005, pp. 1-107.
93. See, refs.[6d], [6g], and [13f]
94. T. Oishi, K. Ando, N. Chida, Chem. Commun. 2001, 1932-1933
95. T. Oishi, K. Ando, K. Inomiya, H. Sato, M. Iida, N. Chida, Org. Lett. 2002, 4, 151-154
96. T. Oishi, K. Ando, K. Inomiya, H. Sato, M. Iida, N. Chida, Bull. Chem. Soc. Jpn. 2002, 75, 1927-1947.
97. Isobe reported excellent pioneer work by using the Overman rearrangement on a sugar scaffold, see M. Isobe, Y. Fukuda, T. Nishikawa, P. Chabert, T. Kawai, T. Goto, Tetrahedron Lett. 1990, 31, 3327-3330
98. T. Nishikawa, M. Asai, N. Ohyabu, M. Isobe, J. Org. Chem. 1998, 63, 188-192
99. T. Nishikawa, M. Asai, N. Ohyabu, N. Yamamoto, Y. Fukuda, M. Isobe, Tetrahedron 2001, 57, 3875-3883; for selected recent reports on the synthesis of natural products and related compounds utilizing the Overman rearrangement, see
100. T. Tsujimoto, T. Nishikawa, D. Urabe, M. Isobe, Synlett 2005, 433-436
101. N. Ohyabu, T. Nishikawa, M. Isobe, J. Am. Chem. Soc. 2003, 125, 8798-8805
102. T. Nishikawa, D. Urabe, K. Yoshida, T. Iwabuchi, M. Asai, M. Isobe, Chem. Eur. J. 2004, 10, 452-462
103. H. Sato, T. Maeba, R. Yanase, A. Yamaji-Hasegawa, T. Kobayashi, N. Chida, J. Antibiot. 2005, 58, 37-49
104. A. E. Hàkansson, A. Palmelund, H. Holm, R. Madsen, Chem. Eur. J. 2006, 12, 3243-3253
105. M. Matveenko, O. J. Kokas, M. G. Banwell, A. C. Willis, Org. Lett. 2007, 9, 3683-3685
106. T. Momose, N. Hama, C. Higashino, H. Sato, N. Chida, Tetrahedron Lett. 2008, 49, 1376-1379
107. H. Sato, K. Sato, M. Iida, H. Yamanaka, T. Oishi, N. Chida, Tetrahedron Lett. 2008, 49, 1943-1947
108. D. P. Dickson, D. J. Wardrop, Org. Lett. 2009, 11, 1341-1344
109. N. Hama, T. Matsuda, T. Sato, N. Chida, Org. Lett. 2009, 11, 2687-2690
110. H. Yamanaka, K. Sato, H. Sato, M. Iida, T. Oishi, N. Chida, Tetrahedron 2009, 65, 9188-9201
111. T. Imaoka, O. Iwamoto, K. Noguchi, K. Nagasawa, Angew. Chem. 2009, 121, 3857-3859
112. Angew. Chem. Int. Ed. 2009, 48, 3799-3801.
113. MacroModel 5.0, Schrödinger, Inc., Portland OR
114. F. Mohamadi, N. G. J. Richards, W. C. Guida, R. Liskamp, M. Lipton, C. Caufield, G. Chang, T. Hendrickson, W. C. Still, J. Comput. Chem. 1990, 11, 440-467.
115. Spartan 5.0.3, Wavefunction Inc., Irvine, CA.
116. J. W. Pratt, N. K. Richtmyer, C. S. Hudson, J. Am. Chem. Soc. 1952, 74, 2200-2205.
117. J. D. Albright, L. Goldman, J. Am. Chem. Soc. 1965, 87, 4214-4216.
118. The stereochemistry of 16 was determined by NOESY experiments. See the Supporting Information.
119. For a review on stereoselective methylation, see:, E. C. Ashby, J. T. Laemmle, Chem. Rev. 1975, 75, 521-546.
120. M. Sridhar, B. A. Kumar, R. Narender, Tetrahedron Lett. 1998, 39, 2847-2850.
121. K. Omura, D. Swern, Tetrahedron 1978, 34, 1651-1660.
122. C.-G. Cho, Y.-K. Lim, K.-S. Lee, I.-H. Jung, M.-Y. Yoon, Synth. Commun. 2000, 30, 1643-1650.
123. In the first-generation synthesis, PMB-protected trichloroimidate i underwent the Overman rearrangement with a similar stereoselectivity (ii/iii 4.3:1).
124. The stereochemistry of 6 and 20 was determined by a NOESY experiment, see the Supporting Information.
125. Hemiaminal 6 existed as an equilibrium mixture of three compounds including the open chain aldehyde (6 / 6' / aldehyde 4:1:0.4), although the stereochemistry was not determined.
126. 2O for 5d at 40°C did not give cyclic carbamate 25 and resulted in recovery of 6 in 91% yield. These results indicated that the cyclic carbamate was formed prior to formation of the aminal.
127. Jones oxidation of primary alcohol 4 provided aldehyde 27, probably because the severe steric hindrance around the aldehyde carbonyl group prevented the formation of the large chromate ester.
128. Carboxylic acid 28 was the reported intermediate in the first-generation synthesis, see Ref.[13f].
129. G. A. Kraus, M. J. Taschner, J. Org. Chem. 1980, 45, 1175-1176
130. G. A. Kraus, B. Roth, J. Org. Chem. 1980, 45, 4825-4830
131. B. S. Bal, W. E. Childers, Jr., H. W. Pinnick, Tetrahedron 1981, 37, 2091-2096.
132. B. V. S. Reddy, L. R. Reddy, E. J. Corey, Tetrahedron Lett. 2005, 46, 4589-4593. Also, see: ref.[12a], [12d] and [12g].
133. W. Yu, Y. Mei, Y. Kang, Z. Hua, Z. Jin, Org. Lett. 2004, 6, 3217-3219.